Clinical Trials Directory

Trials / Completed

CompletedNCT00441064

Effect of High and Low Sodium Diets on Blood Pressure in Hypertensive Patients Treated With Aliskiren

A Randomized, Open-label, Blinded Endpoint, Multi-center, Cross-over Study to Evaluate the Effect of High and Low Sodium Diets on Reduction in Mean 24-hour Ambulatory Blood Pressure in Systolic Hypertensive Patients Treated With Aliskiren (300 mg)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
132 (actual)
Sponsor
Novartis · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study will compare the effects of high and low level sodium (salt) diets on blood pressure in patients with hypertension (high blood pressure) who are taking aliskiren 300 mg.

Conditions

Interventions

TypeNameDescription
DRUGAliskiren

Timeline

Start date
2007-01-01
Primary completion
2007-11-01
Completion
2007-11-01
First posted
2007-02-28
Last updated
2011-03-25
Results posted
2011-03-25

Locations

19 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00441064. Inclusion in this directory is not an endorsement.

Effect of High and Low Sodium Diets on Blood Pressure in Hypertensive Patients Treated With Aliskiren (NCT00441064) · Clinical Trials Directory